{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:32:27Z","timestamp":1786620747631,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,11]]},"group-title":"Microbiology","reference-count":50,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>The ability of respiratory viruses to exploit host immune responses to promote transmission is a defining feature of pandemics. SARS-CoV-2 remains a major global public health threat because of its persistent evolution and capacity to counteract evolving immune defenses. Although the immune evasion properties of the SARS-CoV-2 Spike protein are well characterized, the contributions of other viral proteins to transmission remain poorly understood. Here, we used the infant mouse model to define the role of the accessory protein ORF8 in SARS-CoV-2 spread. We demonstrate that ORF8 supports efficient upper respiratory tract (URT) infection, infectious virus shedding, and host-to-host transmission. Mice infected with a recombinant SARS-CoV-2 strain lacking ORF8 (r\u0394ORF8) had less infectious virus recovered from URT tissues and nasal secretions and transmitted less efficiently than mice infected with the isogenic ancestral strain rWA-1, which contains an intact ORF8. Recombinant viruses encoding naturally occurring ORF8 mutations exhibited distinct transmission phenotypes, with ORF8-deficient viruses resembling r\u0394ORF8. Infection with ORF8-sufficient viruses induced greater macrophage recruitment, inflammatory cytokine production, and type-I interferon (IFN-I) signaling programs than ORF8-deficient viruses. Intranasal IFN\u03b2 supplementation partially restored URT shedding by r\u0394ORF8-infected mice and rescued transmission to contacts, whereas blockade of the type I interferon receptor (IFNAR) in rWA-1-infected index mice reduced contact infection and transmission. Together, these findings demonstrate that ORF8 promotes SARS-CoV-2 transmission by engaging an IFN-I-associated inflammatory and secretory program in the URT that supports virus shedding from the infected host. These data identify ORF8 as a viral determinant of host mucosal responses that promote contagiousness.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Efficient host-to-host transmission underlies the success of respiratory viruses. Although SARS-CoV-2 research has largely focused on the Spike protein, accessory proteins can also shape viral fitness and spread. We previously identified ORF8 as a determinant of SARS-CoV-2 transmission. Here we show that ORF8 promotes SARS-CoV-2 infectious viral shedding and transmission by engaging IFN-I-associated inflammatory and secretory responses in the URT. These findings reveal how a SARS-CoV-2 accessory protein can exploit mucosal antiviral responses to increase host contagiousness.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.08.09.743817","type":"posted-content","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:20:25Z","timestamp":1786526425000},"source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 ORF8 modulates the upper respiratory tract inflammatory response to facilitate transmission"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-9380","authenticated-orcid":false,"given":"Grace O.","family":"Ciabattoni","sequence":"first","affiliation":[{"name":"Department of Microbiology, NYU Grossman School of Medicine, New York, New York, 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-2681","authenticated-orcid":false,"given":"Stacey","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Disease and Immunology, NYU Grossman School of Medicine, New York, NY, 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7451-4958","authenticated-orcid":false,"given":"Marisa E.","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, 21201, USA"},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-0775","authenticated-orcid":false,"given":"Matthew B.","family":"Frieman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-7916","authenticated-orcid":false,"given":"Meike","family":"Dittmann","sequence":"additional","affiliation":[{"name":"Department of Microbiology, NYU Grossman School of Medicine, New York, New York, 10016, USA"},{"name":"Regeneron Pharmaceuticals, Tarrytown, NY, 10591, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9428-1469","authenticated-orcid":false,"given":"Mila B.","family":"Ortigoza","sequence":"additional","affiliation":[{"name":"Department of Microbiology, NYU Grossman School of Medicine, New York, New York, 10016, USA"},{"name":"Department of Medicine, Division of Infectious Disease and Immunology, NYU Grossman School of Medicine, New York, NY, 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026081303501252000_2026.08.09.743817v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2025.10.013"},{"key":"2026081303501252000_2026.08.09.743817v1.2","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.28.25338622:2025.10.28.25338622"},{"key":"2026081303501252000_2026.08.09.743817v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45274-3"},{"key":"2026081303501252000_2026.08.09.743817v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00809-7"},{"key":"2026081303501252000_2026.08.09.743817v1.5","doi-asserted-by":"crossref","first-page":"e0220323","DOI":"10.1128\/mbio.02203-23","article-title":"Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract","volume":"15","year":"2024","journal-title":"mBio"},{"key":"2026081303501252000_2026.08.09.743817v1.6","doi-asserted-by":"crossref","unstructured":"Ahn JH , Kim J , Hong SP , Choi SY , Yang MJ , Ju YS , Kim YT , Kim HM , Rahman MDT , Chung MK , Hong SD , Bae H , Lee CS , Koh GY . 2021. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest 131.","DOI":"10.1172\/JCI148517"},{"key":"2026081303501252000_2026.08.09.743817v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.14"},{"key":"2026081303501252000_2026.08.09.743817v1.8","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1017\/S0950268822001467","article-title":"Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study","volume":"150","year":"2022","journal-title":"Epidemiol Infect"},{"key":"2026081303501252000_2026.08.09.743817v1.9","doi-asserted-by":"crossref","first-page":"1598027","DOI":"10.3389\/fnins.2025.1598027","article-title":"The sneeze reflex in physiological and pathological states: a mini review","volume":"19","year":"2025","journal-title":"Front Neurosci"},{"key":"2026081303501252000_2026.08.09.743817v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3787"},{"key":"2026081303501252000_2026.08.09.743817v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2021.05.003"},{"key":"2026081303501252000_2026.08.09.743817v1.12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(20)30985-3","article-title":"Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study","volume":"21","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026081303501252000_2026.08.09.743817v1.13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-021-00268-z","article-title":"The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes","volume":"7","year":"2021","journal-title":"Cell Discov"},{"key":"2026081303501252000_2026.08.09.743817v1.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016650117"},{"key":"2026081303501252000_2026.08.09.743817v1.15","doi-asserted-by":"publisher","DOI":"10.1002\/open.202100217"},{"key":"2026081303501252000_2026.08.09.743817v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.04.008"},{"key":"2026081303501252000_2026.08.09.743817v1.17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jmv.25762","article-title":"The establishment of reference sequence for SARS-CoV-2 and variation analysis","volume":"92","year":"2020","journal-title":"J Med Virol"},{"key":"2026081303501252000_2026.08.09.743817v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9"},{"key":"2026081303501252000_2026.08.09.743817v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv476"},{"key":"2026081303501252000_2026.08.09.743817v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101724"},{"key":"2026081303501252000_2026.08.09.743817v1.21","doi-asserted-by":"crossref","unstructured":"Flower TG , Buffalo CZ , Hooy RM , Allaire M , Ren X , Hurley JH . 2021. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc Natl Acad Sci U S A 118.","DOI":"10.1073\/pnas.2021785118"},{"key":"2026081303501252000_2026.08.09.743817v1.22","doi-asserted-by":"crossref","first-page":"1035559","DOI":"10.3389\/fimmu.2022.1035559","article-title":"SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions","volume":"13","year":"2022","journal-title":"Front Immunol"},{"key":"2026081303501252000_2026.08.09.743817v1.23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41590-020-0773-7","article-title":"ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection","volume":"21","year":"2020","journal-title":"Nat Immunol"},{"key":"2026081303501252000_2026.08.09.743817v1.24","doi-asserted-by":"crossref","unstructured":"Zhang Y , Chen Y , Li Y , Huang F , Luo B , Yuan Y , Xia B , Ma X , Yang T , Yu F , Liu J , Liu B , Song Z , Chen J , Yan S , Wu L , Pan T , Zhang X , Li R , Huang W , He X , Xiao F , Zhang J , Zhang H . 2021. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota. Proc Natl Acad Sci U S A 118.","DOI":"10.1073\/pnas.2024202118"},{"key":"2026081303501252000_2026.08.09.743817v1.25","doi-asserted-by":"crossref","unstructured":"Beaudoin-Bussieres G , Arduini A , Bourassa C , Medjahed H , Gendron-Lepage G , Richard J , Pan Q , Wang Z , Liang C , Finzi A . 2022. SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity. Viruses 14.","DOI":"10.1101\/2022.03.30.486403"},{"key":"2026081303501252000_2026.08.09.743817v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31757-8"},{"key":"2026081303501252000_2026.08.09.743817v1.27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4049\/jimmunol.2300110","article-title":"SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor","volume":"211","year":"2023","journal-title":"J Immunol"},{"key":"2026081303501252000_2026.08.09.743817v1.28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10875-021-01142-z","article-title":"Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Delta382 Variant Infection","volume":"42","year":"2022","journal-title":"J Clin Immunol"},{"key":"2026081303501252000_2026.08.09.743817v1.29","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1038\/s41467-023-38783-0","article-title":"A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8","volume":"14","year":"2023","journal-title":"Nat Commun"},{"key":"2026081303501252000_2026.08.09.743817v1.30","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2","volume":"7","year":"2020","journal-title":"Natl Sci Rev"},{"key":"2026081303501252000_2026.08.09.743817v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03361-1"},{"key":"2026081303501252000_2026.08.09.743817v1.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204717119"},{"key":"2026081303501252000_2026.08.09.743817v1.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011669"},{"key":"2026081303501252000_2026.08.09.743817v1.34","doi-asserted-by":"crossref","unstructured":"Klinkhammer J , Schnepf D , Ye L , Schwaderlapp M , Gad HH , Hartmann R , Garcin D , Mahlakoiv T , Staeheli P . 2018. IFN-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife 7.","DOI":"10.7554\/eLife.33354"},{"key":"2026081303501252000_2026.08.09.743817v1.35","doi-asserted-by":"crossref","unstructured":"Ortigoza MB , Blaser SB , Zafar MA , Hammond AJ , Weiser JN . 2018. An Infant Mouse Model of Influenza Virus Transmission Demonstrates the Role of Virus-Specific Shedding, Humoral Immunity, and Sialidase Expression by Colonizing Streptococcus pneumoniae. mBio 9.","DOI":"10.1128\/mBio.02359-18"},{"key":"2026081303501252000_2026.08.09.743817v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2943-z"},{"key":"2026081303501252000_2026.08.09.743817v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19891-7"},{"key":"2026081303501252000_2026.08.09.743817v1.38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02012-06"},{"key":"2026081303501252000_2026.08.09.743817v1.39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13567-018-0568-0","article-title":"Ciliostasis of airway epithelial cells facilitates influenza A virus infection","volume":"49","year":"2018","journal-title":"Vet Res"},{"key":"2026081303501252000_2026.08.09.743817v1.40","doi-asserted-by":"crossref","unstructured":"Ivinson K , Deliyannis G , McNabb L , Grollo L , Gilbertson B , Jackson D , Brown LE . 2017. Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection. J Virol 91.","DOI":"10.1128\/JVI.00624-17"},{"key":"2026081303501252000_2026.08.09.743817v1.41","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00026910"},{"key":"2026081303501252000_2026.08.09.743817v1.42","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01055-22"},{"key":"2026081303501252000_2026.08.09.743817v1.43","doi-asserted-by":"crossref","first-page":"102388","DOI":"10.1016\/j.redox.2022.102388","article-title":"SARS-CoV-2 ORF8 reshapes the ER through forming mixed disulfides with ER oxidoreductases","volume":"54","year":"2022","journal-title":"Redox Biol"},{"key":"2026081303501252000_2026.08.09.743817v1.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04638.x"},{"key":"2026081303501252000_2026.08.09.743817v1.45","doi-asserted-by":"publisher","DOI":"10.1159\/000312120"},{"key":"2026081303501252000_2026.08.09.743817v1.46","doi-asserted-by":"crossref","unstructured":"Zangari T , Ortigoza MB , Lokken-Toyli KL , Weiser JN . 2021. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission. mBio 12.","DOI":"10.1128\/mBio.03589-20"},{"key":"2026081303501252000_2026.08.09.743817v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.100"},{"key":"2026081303501252000_2026.08.09.743817v1.48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100436"},{"key":"2026081303501252000_2026.08.09.743817v1.49","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.06.698034"},{"key":"2026081303501252000_2026.08.09.743817v1.50","unstructured":"U.S. Department of Health and Human Services NIoH. 2015. Public Health Service Policy on Humane Care and Use of Laboratory Animals."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.08.09.743817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:50:23Z","timestamp":1786618223000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.08.09.743817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":50,"URL":"https:\/\/doi.org\/10.64898\/2026.08.09.743817","relation":{},"subject":[],"published":{"date-parts":[[2026,8,11]]},"subtype":"preprint"}}